Jump to content

Global Newborn Society: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m adjusted categories
m added categories. Infant mortality is affected by a wide range of issues, which include healthcare, pharmacy, religion (restrictions of breastfeeding in Islam), availability of pediatricians, obstetricians, midwives, social beliefs. Pharmacy and pharmaceutical industry can alter side effects and errors. There is a need for clinical research. Health law (for example, about termination of pregnancy), health standards (maternal health), availability of hospitals, and social workers all matter.
Line 32: Line 32:
[[Category:Nursing]]
[[Category:Nursing]]
[[Category:Nutrition]]
[[Category:Nutrition]]
[[Category:Religion]]
[[Category:Belief]]
[[Category:Society]]

Revision as of 00:37, 24 January 2023

The Global Newborn Society (GNS)[1] is a globally-active, non-profit, registered 501(c)(3) organization focused on promoting the health of newborn infants. They support relevant research; estimate the burden of specific diseases and understand risk-factors; train health professionals; and seek social engagement. These efforts are needed because despite all the scientific progress and social changes over the last two decades, death rates in infants still remain similar to 58-60 years old adults. But, losing a life in infancy is different because of the loss of all possible opportunities over the lifetime.

The GNS, a growing pro bono organization with members now in 122 countries,[2] collaborates closely with many organizations with shared aims from all over the world.[3][4][5][6][7][8][9][10][11] The membership is open to all adults, not to medical professionals alone.[12] The goal is to promote scientifically-proven, financially-viable, and culturally-acceptable decision-making to improve the health of pregnant mothers and their fetuses, newborn babies, and infants during the first 1000 days after birth.

The GNS publishes the scientific journal, the newborn,[13][14] as an independent, officially-registered mouthpiece of the society. The journal is free-of-cost to all readers and has now been in press for more than a year. The goal is develop it into a prime but easily accessible source of peer-reviewed information. The journal covers basic, translational, and clinical research including randomized controlled trials, novel observational studies, and epidemiology. In addition to original research and reviews, they have also published consensus statements, medical guidelines, trials methodology, and relevant outcomes data.[15]

References: